Absci is trading 7% higher at $8.07, rebounding from recent dilution-related weakness as broader U.S. markets show strength.
- The move appears aligned with a risk-on tone in U.S. equities, with major indices gaining between 0.8% and 1.2%.
- Shares are recovering a portion of Friday’s 6.3% decline, which followed profit-taking after a parabolic rally earlier this month.
- There have been no fresh company-specific headlines to drive the price action during this session.